MTD
Mettler-Toledo International Inc. · Healthcare · Medical - Diagnostics & Research
Momentum inputs (comparable managers):
holder breadth -21.1% ·
share flow -2.4% ·
net new positions -20.0%
· formula
Broad distribution: falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 53.78K | $81.23M | n/a | n/a |
| Q2 2026 | 160 | +3 | 14.90M | $19.03B | +6 | −4 |
| Q1 2026 | 161 | 0 | 14.22M | $18.04B | +7 | −8 |
| Q4 2025 | 160 | 0 | 15.72M | $21.91B | +2 | −1 |
| Q3 2025 | 19 | +2 | 8.06M | $9.89B | +2 | −1 |
| Q2 2025 | 15 | -4 | 7.17M | $8.42B | n/a | −4 |
| Q1 2025 | 16 | 0 | 2.78M | $3.28B | n/a | n/a |
| Q4 2024 | 16 | -1 | 2.66M | $3.25B | n/a | −1 |
| Q3 2024 | 16 | 0 | 1.76M | $2.64B | n/a | n/a |
| Q2 2024 | 16 | n/a | 1.72M | $2.40B | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passive) | 2.56M | n/a | $3.00B | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (passive) | 1.95M | n/a | $2.29B | 0.0% | n/c | 1 | SEC ↗ ×22 |
| 3 | State Street Global Advisors ✦ (passive) | 962.81K | -1.2% | $1.13B | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 581.85K | +0.6% | $681.49M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 5 | T. Rowe Price ✦ | 482.55K | +0.3% | $566.86M | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 6 | Norges Bank ✦ (passive) | 306.56K | +1.3% | $360.13M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 7 | Wellington Management ✦ | 79.03K | -6.1% | $92.84M | 0.0% | ▼ Trim | 5 | SEC ↗ ×4 |
| 8 | Arrowstreet Capital ✦ | 68.26K | +19.0% | $80.19M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 9 | Marshall Wace ✦ | 59.82K | -36.9% | $70.27M | 0.1% | ▼ Trim | 5 | SEC ↗ ×4 |
| 10 | Fidelity (FMR) ✦ | 55.73K | n/a | $65.47M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 11 | AQR Capital Management ✦ | 41.32K | +90.7% | $48.54M | 0.0% | ▲ Add | 5 | SEC ↗ ×4 |
| 12 | Adage Capital Partners ✦ | 14.06K | +75.3% | $16.51M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 6.94K | -77.0% | $8.16M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 14 | Millennium Management ✦ | 1.78K | -91.6% | $2.09M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 551 | -57.1% | $647,271 | 0.0% | ▼ Trim | 5 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Citadel Advisors | $73.22M | was 0.1% |
| Point72 Asset Management | $47.40M | was 0.1% |
| Renaissance Technologies | $21.61M | was 0.0% |
| Two Sigma Investments | $2.33M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 815 holders, 19.62M shares, $23.18B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 942 sh · $1.34M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology